Inspire Investing, LLC Intercept Pharmaceuticals, Inc. Transaction History

Inspire Investing, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$14.28 - $19.53 $455,075 - $622,382	-31,868 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$12.99 - $20.47 $413,965 - $652,337	31,868 New	31,868 $473,000
Q2 2020 Aug 12, 2020	SELL	$46.7 - $92.04 $124,315 - $245,010	-2,662 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$48.35 - $118.68 $39,695 - $97,436	821 Added 44.6%	2,662 $168,000
Q4 2019 Jan 24, 2020	SELL	$57.36 - $124.1 $75,026 - $162,322	-1,308 Reduced 41.54%	1,841 $228,000
Q3 2019 Nov 13, 2019	BUY	$58.69 - $80.46 $184,814 - $253,368	3,149 New	3,149 $209,000
Q1 2018 Apr 13, 2018	SELL	$52.72 - $67.25 $48,344 - $61,668	-917 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$58.2 - $72.76 $53,369 - $66,720	917	917 $54,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.